DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Primary and central hypothyroidism

Essential points for quick revision.

!
Escalate

Hypothermia, reduced consciousness, hypoventilation, bradycardia, hypotension, hypoglycaemia or severe hyponatraemia in suspected hypothyroidism requires emergency endocrine and critical-care support. In central disease, possible cortisol deficiency is immediately dangerous and glucocorticoid treatment must precede thyroid replacement when clinically indicated.

Synopsis

Distinguish thyroid-gland failure from pituitary or hypothalamic disease, replace hormone safely, and protect patients with possible adrenal insufficiency or special physiological needs.

  • Primary hypothyroidism produces raised TSH with low free T4; central hypothyroidism produces low free T4 with TSH that is low, normal or biologically inadequate.
  • Autoimmune thyroiditis, thyroidectomy and radioiodine are frequent primary causes; pituitary tumours, surgery, radiotherapy, apoplexy and infiltrative disease underlie many central cases.
  • Symptoms such as tiredness, weight gain, constipation, dry skin, cold intolerance and cognitive slowing are common but nonspecific, so diagnosis requires credible biochemistry.

Key red flags

Central endocrine clues

Headache, visual-field symptoms, amenorrhoea, infertility, reduced libido, loss of body hair, post-partum haemorrhage history, polyuria or previous pituitary treatment should shift attention from the thyroid gland to the sellar axis.

Investigation priorities

01
TSH and free T4First step

Confirm hypothyroidism and locate dysfunction within the axis.

Management branches

Primary diagnosisConfirm and begin replacement

Raised TSH with free T4 below the local reference interval.

  1. Assess severity, pregnancy possibility, cardiovascular disease, previous thyroid intervention, medicines and features of adrenal or pituitary disease before prescribing.
  2. Start levothyroxine using NICE age and cardiac-risk principles, explain consistent administration and separate it from relevant food, iron and calcium exposure.
Persistent symptomsReassess before alternative hormone

Symptoms continue after TSH normalises on a stable levothyroxine regimen.

Key medicines

Levothyroxine for primary hypothyroidismAdults under 65 without cardiovascular disease: consider 1.6 micrograms/kg once daily, rounded to the nearest 25 micrograms; age 65 or over, or cardiovascular disease: consider 25 to 50 micrograms once daily with titration.
Levothyroxine for central hypothyroidismIndividualised once-daily replacement prescribed and titrated by endocrinology using free T4, symptoms, age and cardiac risk rather than a TSH target.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom